Literature DB >> 11110797

Fragile T-stem in disease-associated human mitochondrial tRNA sensitizes structure to local and distant mutations.

S O Kelley1, S V Steinberg, P Schimmel.   

Abstract

Mutations in human mitochondrial isoleucine tRNA (hs mt tRNA(Ile)) are associated with cardiomyopathy and opthalmoplegia. A recent study showed that opthalmoplegia-related mutations gave rise to severe decreases in aminoacylation efficiencies and that the defective mutant tRNAs were effective inhibitors of aminoacylation of the wild-type substrate. The results suggested that the effectiveness of the mutations was due in large part to an inherently fragile mitochondrial tRNA structure. Here, we investigate mutant tRNAs associated with cardiomyopathy, and a series of rationally designed second-site substitutions introduced into both opthalmoplegia- and cardiomyopathy-related mutant tRNAs. A source of structural fragility was uncovered. An inherently unstable T-stem appears susceptible to misalignments. This susceptibility sensitizes both domains of the L-shaped tRNA structure to base substitutions that are deleterious. Thus, the fragile T-stem makes the structure of this human mitochondrial tRNA particularly vulnerable to local and distant mutations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110797     DOI: 10.1074/jbc.M008320200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  A La protein requirement for efficient pre-tRNA folding.

Authors:  Ghadiyaram Chakshusmathi; Sang Do Kim; Douglas A Rubinson; Sandra L Wolin
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

2.  Pathology-related substitutions in human mitochondrial tRNA(Ile) reduce precursor 3' end processing efficiency in vitro.

Authors:  Louis Levinger; Richard Giegé; Catherine Florentz
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

Review 3.  Mitochondrial tRNA 3' end metabolism and human disease.

Authors:  Louis Levinger; Mario Mörl; Catherine Florentz
Journal:  Nucleic Acids Res       Date:  2004-10-11       Impact factor: 16.971

Review 4.  The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis.

Authors:  Paul Schimmel
Journal:  Nat Rev Mol Cell Biol       Date:  2017-09-06       Impact factor: 94.444

5.  Impairment of mitochondrial tRNAIle processing by a novel mutation associated with chronic progressive external ophthalmoplegia.

Authors:  A Schaller; R Desetty; D Hahn; C B Jackson; J-M Nuoffer; S Gallati; L Levinger
Journal:  Mitochondrion       Date:  2011-02-01       Impact factor: 4.160

6.  Recurrent myoglobinuria in a sporadic patient with a novel mitochondrial DNA tRNA(Ile) mutation.

Authors:  Valentina Emmanuele; Evangelia Sotiriou; Maryam Shirazi; Kurenai Tanji; Ronald G Haller; Katja Heinicke; Peter E Bosch; Michio Hirano; Salvatore DiMauro
Journal:  J Neurol Sci       Date:  2011-02-15       Impact factor: 3.181

7.  Aminoacylation properties of pathology-related human mitochondrial tRNA(Lys) variants.

Authors:  Marie Sissler; Mark Helm; Magali Frugier; Richard Giege; Catherine Florentz
Journal:  RNA       Date:  2004-05       Impact factor: 4.942

8.  Pathology-related mutation A7526G (A9G) helps in the understanding of the 3D structural core of human mitochondrial tRNA(Asp).

Authors:  Marie Messmer; Agnès Gaudry; Marie Sissler; Catherine Florentz
Journal:  RNA       Date:  2009-06-17       Impact factor: 4.942

9.  The pathogenic U3271C human mitochondrial tRNA(Leu(UUR)) mutation disrupts a fragile anticodon stem.

Authors:  Lisa M Wittenhagen; Marc D Roy; Shana O Kelley
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

10.  Decreased aminoacylation in pathology-related mutants of mitochondrial tRNATyr is associated with structural perturbations in tRNA architecture.

Authors:  Luc Bonnefond; Catherine Florentz; Richard Giegé; Joëlle Rudinger-Thirion
Journal:  RNA       Date:  2008-02-11       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.